Endoneurial remodeling by TNFα and TNFα-releasing proteases. A spatial and temporal co-localization study in painful neuropathy

Journal of the Peripheral Nervous System

Volumn 7, Issue 1, 2002, Pages 28-36

  Shubayev, Veronica I ^a,b   Myers, Robert ^a,b  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic constriction injury; MMP; Neuropathic pain; TNF

Indexed keywords

GELATINASE; GELATINASE B; HYDROXAMIC ACID DERIVATIVE; MATRIX METALLOPROTEINASE INHIBITOR; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR ALPHA RELEASING PROTEASE; UNCLASSIFIED DRUG; ADAM PROTEIN; GELATINASE A; METALLOPROTEINASE; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL MIGRATION; CHRONICITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DESIGN; DRUG MECHANISM; DRUG SELECTIVITY; ENDONEURIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME REGULATION; FEMALE; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; NERVE DEGENERATION; NERVE INJURY; NEUROPATHY; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; REMYELINIZATION; SCHWANN CELL; SCIATIC NERVE; SPINAL GANGLION; ACUTE DISEASE; ANIMAL; CHRONIC DISEASE; ENZYMOLOGY; IMMUNOLOGY; ISCHIALGIA; METABOLISM; PATHOLOGY; PERIPHERAL NERVE; SCIATIC NEUROPATHY; SPRAGUE DAWLEY RAT;

ACUTE DISEASE; ADAM PROTEINS; ANIMALS; CHRONIC DISEASE; FEMALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; PERIPHERAL NERVES; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NEUROPATHY; SCIATICA; TUMOR NECROSIS FACTOR-ALPHA; WALLERIAN DEGENERATION;

EID: 0036006118     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1529-8027.2002.02003.x     Document Type: Article

References (58)

1. Substance P selectively activates TNF-alpha gene expression in murine mast cells
2. A peripheral mononeuropathy in rat that produces disorders of pain sensations like those seen in man
3. A metalloproteinase disintegrin that releases tumor necrosis factor-α from cells
4. Matrix metalloproteinases degrade myelin basic protein
5. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: An overview
6. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-α inhibitor
7. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions
8. MMP-2 and MMP-9 increase the neurite-promoting potential of Schwann cell basal laminae and are upregulated in degenerated nerve
9. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion
10. Sciatic inflammatory neuritis (SIN): Behavioral allodynia is paralled by peri-sciatic proinflammatory cytokine and superoxide production
11. Processing of TNFα precursor by metalloproteinases
12. TNF-alpha released by comigrating monocytes promotes transendothelial migration of activated lymphocytes
13. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein
14. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteinases
15. Degeneration and regeneration in the peripheral nervous system
16. The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system
17. Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790
18. Schwann cell basal lamina and nerve regeneration
19. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane
20. Focal effects of mononuclear leukocyte transendothelial migration: TNF-alpha production by migrating monocytes promotes subsequent migration of lymphocytes
21. Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS
22. The role of macrophages in immune-mediated damage to the peripheral nervous system
23. Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis
24. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré Syndrome
25. Basement membrane and repair of injury to peripheral nerve: Defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1
26. Cytokines, signal transduction and inflammatory demyelination: Review and hypothesis
27. T cell gelatinases mediate basement membrane transmigration in vitro
28. Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy
29. Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis
30. Extracellular matrix degradation by metalloproteinases and central nervous system diseases
31. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation
32. Hyperalgesic action of cytokines on the peripheral nervous system
33. The role of focal nerve ischemia and Wallerian degeneration in peripheral nerve injury producing hyperesthesia
34. Activation mechanisms of matrix metalloproteinases
35. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes
36. Metalloproteinases and their tissue inhibitors in multiple sclerosis
37. Tumor necrosis factor-α: A neuromodulator in the CNS
38. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis
39. Vascular changes and demyelination induced by the intraneural injection of tumor necrosis factor
40. A combined inhibitor of matrix metalloproteinase activity and TNF-α processing attenuates experimental autoimmune neuritis
41. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase
42. Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood-brain barrier: An expanded therapeutic window
43. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: Relation to blood-brain barrier injury
44. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages
45. Neuronal extracellular proteases facilitate cell migration, axonal growth, and pathfinding
46. Upregulation and interaction of TNF-α and gelatinases A and B in painful peripheral nerve injury
47. Axonal transport of TNF-α in painful neuropathy: Distribution of ligand tracer and TNF receptors
48. A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy
49. Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat
50. Tumour necrosis factor-α induces ectopic activity in nociceptive primary afferent fibres
51. Functional interplay between gelatinases and hyperalgesia in endotoxin-induced localized inflammatory pain
52. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors
53. Schwann cells produce TNF-alpha: Expression in injured and non-injured nerves
54. Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-α expression
55. Paradoxical effects of synthetic metallo-proteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF processing in RA synovial membrane cell cultures
56. The family of matrix metalloproteinases
57. Matrix metalloproteinases and diseases of the CNS
58. Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue